A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices

P. Calabresi, A. Siniscalchi, A. Pisani, A. Stefani, N. B. Mercuri, G. Bernardi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We studied the action of the new antiepileptic drugs lamotrigine (LTG), GP 47779 (the active metabolite of oxcarbazepine), and felbamate (FBM) on stimulus-evoked field potentials recorded from rat prefrontal and frontal cortical slices. In the presence of physiologic concentrations of extracellular magnesium (1.2 mM) the field potential amplitude was not affected by the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, 2- amino-5-phosphonovalerate (APV), while it was blocked by the non-NMDA glutamate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). When magnesium was removed from the bathing medium, there was a significant NMDA-mediated component of the field potential. LTG and GP 47779 decreased, in a dose-dependent manner, the field potential amplitude under both experimental conditions. FBM caused a dose-related decrease of the field potential amplitude only in the absence of external magnesium, suggesting a selective interaction with an NMDA-mediated component of this potential. These findings indicate that the reduction of cortical excitatory transmission might represent a common target for new antiepileptic drugs.

Original languageEnglish
Pages (from-to)557-562
Number of pages6
JournalNeurology
Volume47
Issue number2
Publication statusPublished - Aug 1996

Fingerprint

10,11-dihydro-10-hydroxycarbamazepine
felbamate
Magnesium
Excitatory Amino Acid Antagonists
N-Methylaspartate
Anticonvulsants
6-Cyano-7-nitroquinoxaline-2,3-dione
2-Amino-5-phosphonovalerate
D-Aspartic Acid
N-Methyl-D-Aspartate Receptors
Evoked Potentials
lamotrigine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices. / Calabresi, P.; Siniscalchi, A.; Pisani, A.; Stefani, A.; Mercuri, N. B.; Bernardi, G.

In: Neurology, Vol. 47, No. 2, 08.1996, p. 557-562.

Research output: Contribution to journalArticle

@article{b7f494828cb34657bfa635d4fb5d70f5,
title = "A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices",
abstract = "We studied the action of the new antiepileptic drugs lamotrigine (LTG), GP 47779 (the active metabolite of oxcarbazepine), and felbamate (FBM) on stimulus-evoked field potentials recorded from rat prefrontal and frontal cortical slices. In the presence of physiologic concentrations of extracellular magnesium (1.2 mM) the field potential amplitude was not affected by the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, 2- amino-5-phosphonovalerate (APV), while it was blocked by the non-NMDA glutamate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). When magnesium was removed from the bathing medium, there was a significant NMDA-mediated component of the field potential. LTG and GP 47779 decreased, in a dose-dependent manner, the field potential amplitude under both experimental conditions. FBM caused a dose-related decrease of the field potential amplitude only in the absence of external magnesium, suggesting a selective interaction with an NMDA-mediated component of this potential. These findings indicate that the reduction of cortical excitatory transmission might represent a common target for new antiepileptic drugs.",
author = "P. Calabresi and A. Siniscalchi and A. Pisani and A. Stefani and Mercuri, {N. B.} and G. Bernardi",
year = "1996",
month = "8",
language = "English",
volume = "47",
pages = "557--562",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices

AU - Calabresi, P.

AU - Siniscalchi, A.

AU - Pisani, A.

AU - Stefani, A.

AU - Mercuri, N. B.

AU - Bernardi, G.

PY - 1996/8

Y1 - 1996/8

N2 - We studied the action of the new antiepileptic drugs lamotrigine (LTG), GP 47779 (the active metabolite of oxcarbazepine), and felbamate (FBM) on stimulus-evoked field potentials recorded from rat prefrontal and frontal cortical slices. In the presence of physiologic concentrations of extracellular magnesium (1.2 mM) the field potential amplitude was not affected by the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, 2- amino-5-phosphonovalerate (APV), while it was blocked by the non-NMDA glutamate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). When magnesium was removed from the bathing medium, there was a significant NMDA-mediated component of the field potential. LTG and GP 47779 decreased, in a dose-dependent manner, the field potential amplitude under both experimental conditions. FBM caused a dose-related decrease of the field potential amplitude only in the absence of external magnesium, suggesting a selective interaction with an NMDA-mediated component of this potential. These findings indicate that the reduction of cortical excitatory transmission might represent a common target for new antiepileptic drugs.

AB - We studied the action of the new antiepileptic drugs lamotrigine (LTG), GP 47779 (the active metabolite of oxcarbazepine), and felbamate (FBM) on stimulus-evoked field potentials recorded from rat prefrontal and frontal cortical slices. In the presence of physiologic concentrations of extracellular magnesium (1.2 mM) the field potential amplitude was not affected by the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, 2- amino-5-phosphonovalerate (APV), while it was blocked by the non-NMDA glutamate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). When magnesium was removed from the bathing medium, there was a significant NMDA-mediated component of the field potential. LTG and GP 47779 decreased, in a dose-dependent manner, the field potential amplitude under both experimental conditions. FBM caused a dose-related decrease of the field potential amplitude only in the absence of external magnesium, suggesting a selective interaction with an NMDA-mediated component of this potential. These findings indicate that the reduction of cortical excitatory transmission might represent a common target for new antiepileptic drugs.

UR - http://www.scopus.com/inward/record.url?scp=0029812585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029812585&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 557

EP - 562

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -